Dianthus Therapeutics, Inc.DNTHNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P6
Near historical low
vs 5Y Ago
-11.2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -53.77% |
| Q3 2025 | -27.89% |
| Q2 2025 | 13.53% |
| Q1 2025 | -0.68% |
| Q4 2024 | -29.04% |
| Q3 2024 | -46.39% |
| Q2 2024 | 2.76% |
| Q1 2024 | -26.04% |
| Q4 2023 | -891.85% |
| Q3 2023 | 131.64% |
| Q2 2023 | 54.00% |
| Q1 2023 | -16.19% |
| Q4 2022 | -154.05% |
| Q3 2022 | 197.16% |
| Q2 2022 | 14.63% |
| Q1 2022 | -25.82% |
| Q4 2021 | -11.54% |
| Q3 2021 | -8.21% |
| Q2 2021 | 22.50% |
| Q1 2021 | -22.14% |
| Q4 2020 | 4.82% |
| Q3 2020 | 24.87% |
| Q2 2020 | -15.30% |
| Q1 2020 | -6.59% |
| Q4 2019 | -35.80% |
| Q3 2019 | 23.46% |
| Q2 2019 | -0.65% |
| Q1 2019 | -18.31% |
| Q4 2018 | -19.67% |
| Q3 2018 | -15.81% |
| Q2 2018 | 5.15% |
| Q1 2018 | -16.67% |
| Q4 2017 | -51.24% |
| Q3 2017 | -19.42% |
| Q2 2017 | -13.10% |
| Q1 2017 | 0.00% |